CDSCO requests Pharmaceutical and Bio-pharmaceutical manufacturing units to participate in RPL-BICE under the PMKVY 2016-20

Jun 28, 2019 | by Avantis RegTech Legal Research Team

Industry Specific Compliance

The Central Drugs Standard Control Organization (CDSCO) on June 25, 2019, has advised all the Pharmaceutical Associations to request their members having the pharmaceutical and bio-pharmaceutical manufacturing units to actively participate in the Recognition of Prior Learning with Best-in-Class Employers (RPL-BICE) under Pradhan Mantri Kaushal Vikas Yojana (PMKVY) 2016-20. The RPL under PMKVY 2016-20 was initiated by Ministry of Skill Development and Entrepreneurship (MSDE) with the aim to recognize the existing skill sets & prior experience of the beneficiaries and provide certification after assessment through RPL camps, employer premises and centres. 

The idea of RPL with Best in Class Employers (RPL- BICE) is launched considering the immense potential of this mode of RPL. The RPL will enable advancement of formalized skilling in the industry which will serve as a benchmark for internal improvements and comparison amongst the various players in the industry. The RPL-BICE certificate and formalization will lead to an increase in skilled manpower, improved safety and productivity. The Government of India had entrusted the work relating to development of qualification packs (National Occupational Standards) to the Life Sciences Sector Skill Development Council (LSSSDC) with the objective of upgrading the skills of persons employed in the Life Sciences sector in the country.

Considering the importance of RPL, MSDE has requested Ministry of Health and Family Welfare to issue an advisory for active participation in the RPL-BICE.


Related Updates

Alternate Text

Get updates on the go on RuleZbook Mobile App.